Recombinant Nerolidol Biosynthesis for High-Purity Fermentation Yield

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing nerolidol, an industrially important isoprenoid, are inefficient, costly, and result in low-quality products with impurities, as they rely on plant extraction or chemical synthesis from non-renewable sources, which are less safe and environmentally unfriendly.

Innovation Solution

A recombinant cell expressing a terpenoid synthase gene, such as strawberry nerolidol synthase, with specific genetic modifications to enhance nerolidol biosynthesis, using microbial fermentation processes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If plant extraction is used to produce nerolidol, then natural source is obtained, but production efficiency is low and product purity is poor

Engineering Contradiction:
Improvenatural source authenticityVSAvoidproduction efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent uses recombinant microorganisms as an intermediary system to produce nerolidol. The microorganisms are engineered with plant terpenoid synthase genes and modified metabolic pathways, serving as a bridge between plant-based natural production and microbial fermentation efficiency, thereby achieving both natural authenticity and high productivity

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent modifies multiple parameters including genetic composition (introducing terpenoid synthase genes), metabolic pathway flux (overexpressing rate-limiting enzymes), and cellular composition (increasing precursor availability) to transform the microbial system into an efficient nerolidol production platform while maintaining natural product quality

Inventive Principle:
Principle #35Parameter changes

2Ease of manufacture

If chemical synthesis from linalool is used, then production cost is reduced, but product safety and environmental friendliness deteriorate

Engineering Contradiction:
Improveproduction costVSAvoidenvironmental safety
Core Design Contradiction:
Ease of manufactureVSObject-affected harmful factors

Solution Approach 1:

The patent replaces chemical synthesis mechanisms with biological enzymatic mechanisms. By using recombinant microorganisms expressing terpenoid synthase genes, the system substitutes chemical catalysis with biological catalysis, eliminating harmful chemicals and byproducts while maintaining cost-effectiveness through scalable fermentation processes

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The recombinant microorganisms perform self-service by utilizing their own metabolic pathways to synthesize nerolidol from renewable carbon sources. The engineered cells automatically convert precursors like acetyl-CoA and mevalonate into nerolidol through expressed terpenoid synthases, eliminating the need for external chemical reagents and reducing environmental impact

Inventive Principle:
Principle #25Self-service

3Reliability

If plant extraction is used, then natural nerolidol is obtained, but product purity is low with many impurities

Engineering Contradiction:
Improvenatural source authenticityVSAvoidproduct purity
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The patent extracts and utilizes specific functional genes (terpenoid synthase genes) from plants and transfers them into microbial systems. This selective extraction of the key biosynthetic gene allows the microorganism to produce nerolidol as the primary product without co-extracting impurities associated with whole plant extraction

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent implements local quality optimization by specifically engineering the nerolidol biosynthetic pathway in microorganisms while modifying only the relevant metabolic nodes. This targeted approach ensures high nerolidol purity by focusing genetic modifications on the specific pathway leading to nerolidol without affecting other cellular metabolites that could become impurities

Inventive Principle:
Principle #3Local quality

4Productivity

If microbial fermentation is used to produce nerolidol, then production efficiency is improved, but product yield was previously low

Engineering Contradiction:
Improveproduction efficiencyVSAvoidproduct yield
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

The patent performs preliminary actions by pre-modifying the microbial host with multiple genetic improvements before nerolidol production. This includes introducing terpenoid synthase genes, overexpressing rate-limiting enzymes in the mevalonate pathway, and blocking competing pathways, thereby preparing the cellular machinery in advance to achieve both high efficiency and high yield simultaneously

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent merges multiple genetic modifications into a single integrated microbial strain. By combining terpenoid synthase gene introduction, rate-limiting enzyme overexpression, and competing pathway blockade in one organism, the system achieves synergistic effects that simultaneously improve production efficiency and product yield beyond what single modifications could achieve

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves high-purity and high-yield production of nerolidol, surpassing previous microbial production levels by several orders of magnitude, providing a sustainable and cost-effective alternative.

Implementation Method 1

using microbial fermentation processes

Methodology Applied
Scientific EffectFermentation: Fermentation

Implementation Method 2

expressing a terpenoid synthase gene, such as strawberry nerolidol synthase

Methodology Applied
Scientific EffectEnzymatic catalysis: Enzyme

Data Source

PatentUS20260071241A1Biosynthesis of isoprenoid
Publication Date: 2026.03.12 AGENCY FOR SCI TECH & RES
  • US20260071241A1 patent drawing
  • US20260071241A1 patent drawing
  • US20260071241A1 patent drawing

AI summary

There is provided a recombinant cell comprising a plasmid expressing terpenoid synthase gene and one or more modification to the gene of the recombinant cell. Also provided is a recombinant cell for use in biosynthesis and a method of producing isoprenoid/terpenoid.